Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

The STELVIO trial, a game changer for bronchoscopic lung volume reduction in patients with severe emphysema

Rein Posthuma, Lowie E.G.W. Vanfleteren
Breathe 2020 16: 200004; DOI: 10.1183/20734735.0004-2020
Rein Posthuma
1CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands
2Dept of Respiratory Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands
3NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rein Posthuma
  • For correspondence: reinposthuma@ciro-horn.nl
Lowie E.G.W. Vanfleteren
1CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands
2Dept of Respiratory Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands
4COPD Centre, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Timeline of important studies in the field of interventional lung volume reduction (LVR). RCT: randomised controlled trial; EU: European Union; FDA: Food and Drug Administration.

PreviousNext
Back to top
Vol 16 Issue 1 Table of Contents
Breathe: 16 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The STELVIO trial, a game changer for bronchoscopic lung volume reduction in patients with severe emphysema
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
The STELVIO trial, a game changer for bronchoscopic lung volume reduction in patients with severe emphysema
Rein Posthuma, Lowie E.G.W. Vanfleteren
Breathe Mar 2020, 16 (1) 200004; DOI: 10.1183/20734735.0004-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The STELVIO trial, a game changer for bronchoscopic lung volume reduction in patients with severe emphysema
Rein Posthuma, Lowie E.G.W. Vanfleteren
Breathe Mar 2020, 16 (1) 200004; DOI: 10.1183/20734735.0004-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Expert opinion

  • Lung cancer screening by volume CT
  • In pursuit of the primary
  • A rare complication in a case of nonsmall cell lung carcinoma
Show more Expert opinion

Landmark papers in respiratory medicine

  • Bioartificial lungs using de- and recellularisation approaches
  • Using a molecular classifier to identify UIP in TBLB samples
  • The era of CFTR modulators
Show more Landmark papers in respiratory medicine

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2022 by the European Respiratory Society